Chemicals and pharmaceuticals · RYAM

RAYONIER ADVANCED MATERIALS INC.

12 filings mentioning 7 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
7topics disclosed
Chemicals and pharmaceuticalsindustry
FLbased in

Across 12 filings we hold, RAYONIER ADVANCED MATERIALS INC. has written down 7 of the topics we track. That places it 1 of 5 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

RYAM Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something RAYONIER ADVANCED MATERIALS INC. has written into a filing. Not what they said. What applies once they have said it.

NIST Cybersecurity Framework 2.078
ISO 27001:202242
ISO 37001:201639
ISO 22301:201938
ASD Strategies to Mitigate Cyber Security Incidents29
ISO 3700126
CIRCIA (Cyber Incident Reporting for Critical Infrastructure Act)12
COSO Internal Control9
CSRD9
NIST SP 800-615

10 frameworks, 287 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Cybersecurity Incident102026-05-05
Restatement82024-11-08
Ransomware42025-03-06
Consent Order12020-12-23
Enforcement Action12024-10-29
Business Continuity12025-03-06
ESG Reporting12025-03-06

When it filed

Filings we hold, by year. Hover a bar for the count.

19
20
21
22
23
24
25
26

Recent filings

FiledFormItem
2026-05-058-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2026-03-038-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2025-11-048-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2025-08-058-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2025-05-068-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2025-03-0610-Kfiling
2025-03-058-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2024-11-088-KEntry into a material agreement, Item 1.02, Item 2.03filing
2024-11-058-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2024-10-298-KEntry into a material agreement, Item 2.03, Other material eventfiling
2024-08-068-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2024-05-078-KResults of operations, the earnings release, Financial statements and exhibitsfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition